The pharmaceutical division is actively seeking partnerships for enlarging the RX portfolio with innovative therapeutic agents.
Kwizda is committed to continued growth via acquisition, in-licensing new opportunities and forming mutually beneficial business partnerships.
Our in-licensing goals:
Kwizda´s management experience across a wide range of pharmaceutical brands and markets allows rapid assessment of opportunities. At this stage in Kwizda´s development we are willing to look at following therapeutic areas:
- Cardiovascular diseases
- Diabetes and metabolic diseases
- Pain management
- Selected GP products
We are open to discuss different co-operation models and ensure a rapid market access. Let´s start to negotiate!
We are looking for:
- Late Stage developments
- Rx products in registration
- Ready-to-be marketed products
- In-licensing and exclusive distribution
- Co-marketing – Co- branding - Second license